sulfamic acid has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, TJ; Bryant, JL; Gieling, RG; Meredith, SL; Supuran, CT; Telfer, BA; Walker, L; White, A; Williams, KJ | 1 |
| Csuk, R; Heller, L; Sommerwerk, S | 1 |
2 other study(ies) available for sulfamic acid and Cancer of Lung
| Article | Year |
|---|---|
Novel carbonic anhydrase IX-targeted therapy enhances the anti-tumour effects of cisplatin in small cell lung cancer.
Topics: Animals; Antineoplastic Agents; Carbonic Anhydrase IX; Cell Line, Tumor; Cisplatin; Drug Synergism; Enzyme Inhibitors; Humans; Lung Neoplasms; Mice; Mice, Nude; Phenylurea Compounds; Small Cell Lung Carcinoma; Sulfonic Acids; Xenograft Model Antitumor Assays | 2018 |
Synthesis and cytotoxic activity of pentacyclic triterpenoid sulfamates.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; HT29 Cells; Humans; Inhibitory Concentration 50; Lung Neoplasms; MCF-7 Cells; Mice; Molecular Structure; NIH 3T3 Cells; Pentacyclic Triterpenes; Structure-Activity Relationship; Sulfonic Acids | 2015 |